Acasti Pharma, Inc.

Acasti Pharma, Inc.

Acasti Pharma, Inc.

Overview
Date Founded

2002

Headquarters

545, Promenade du Centropolis, Suite 100, Laval, QC, H7T 0A3, CAN

Type of Company

Public

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Medical Support Services
Hospitals & Patient Services
Biotechnology

Company Description

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Contact Data
Trying to get in touch with decision makers at Acasti Pharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer, Secretary & Director

Chief Financial Officer

Chief Operating Officer & Chief Scientific Officer

Executive Chairman

Director, Investor Relations

Board of Directors

Executive Chairman at Acasti Pharma, Inc.

Director at REV Group, Inc.

Director at Presagia Corp.

President, Chief Executive Officer, Secretary & Director at Acasti Pharma, Inc.

Paths to Acasti Pharma, Inc.
Potential Connections via
Relationship Science
You
Acasti Pharma, Inc.
Recent Transactions
Details Hidden

Acasti Pharma, Inc. issued CAD Common Shares

Details Hidden

Acasti Pharma, Inc. issued USD Common Shares

Details Hidden

Acasti Pharma, Inc. issued CAD Units Consisting of Common Shares and Warants

Transaction Advisors
Escrow Agent

Advised onAcasti Pharma, Inc. issued CAD Common Shares

Auditor

Advised onAcasti Pharma, Inc. issued USD Common Shares

Auditor

Advised onAcasti Pharma, Inc. issued USD Units

Managing Director

Advised onAcasti Pharma, Inc. issued USD Common Shares

Legal Advisor

Advised onAcasti Pharma, Inc. issued USD Common Shares

Advisors & Consultants
Legal Advisor

Partner at Osler, Hoskin & Harcourt LLP

Advisor

Chief Financial Officer at Tetra Bio-Pharma, Inc.

Legal Advisor

Partner at Osler, Hoskin & Harcourt LLP

Key Stats and Financials As of 2020
Market Capitalization
$98.7M
Total Enterprise Value
$18M
Earnings Per Share
$-0.3
Revenue
$0
Net Profit
$-25.5M
EBITDA
$-22.4M
Total Debt
$147K
Total Equity
$13M
TEVNet Income
-0.71x
Debt TEV
0.01x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Non-Profit Donations & Grants
$1,000 - $4,999
2011
Suppliers
Neptune Wellness Solutions, Inc. Hospitals & Patient Services | Laval, Canada

Neptune Wellness Solutions, Inc. is a diversified health and wellness company. It engages in building a broad portfolio of quality, affordable consumer products in response to long-term secular trends and market demand for natural, plant-based, sustainable and purpose-driven lifestyle brands. The company utilizes a flexible, cost efficient manufacturing and supply chain infrastructure that can be scaled up and down or into adjacent product categories to identify opportunities, quickly adapt to consumer preferences and demand, and bring new products to market through its mass retail partners and e-commerce channels. Neptune Wellness Solutions was founded by Henri Harland on October 9, 1998 and is headquartered in Laval, Canada.

Aker ASA Engineering, Construction & Architecture | Lysaker, Norway

Aker ASA is an industrial investment company that owns and carries out industrial and capital management. The company operates its business through the Industrial Holdings and Financial Investments segments. The Industrial Holdings segment comprises the company's ownership interests in Aker Solutions, Kvaerner, Det Norske Oljeselskap, Ocean Yield, and Aker BioMarine. The Financial Investments segment includes cash, real estate, shares in funds, and other financial assets. The company was founded by Peter Steenstrup in 1841 and is headquartered in Lysaker, Norway.

Competitors
GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

AbbVie, Inc. Pharmaceuticals - North Chicago, IL

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on 2013 and is headquartered in North Chicago, IL.

Amarin Corporation Plc Pharmaceuticals - Dublin, Ireland

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Acasti Pharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Acasti Pharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Acasti Pharma, Inc..